Nosocomial outbreak of SARS-CoV-2 infection in a haematological unit - High mortality rate in infected patients with haematologic malignancies

J Clin Virol. 2020 Sep:130:104574. doi: 10.1016/j.jcv.2020.104574. Epub 2020 Aug 1.

Abstract

Background: Here we report nosocomial outbreak of COVID-19 among patients in a haematological unit. To our knowledge this is the first report from Central Europe comparing morbidity and mortality in infected and non-infected patients after exposure to SARS-CoV-2.

Methods: The outbreak involved 39 individuals: 19 patients and 20 health care workers. The SARS-CoV-2 test by nasopharyngeal swabs was performed by real-time RT-PCR. Exposed patients were divided into two groups: quarantine patients with and without COVID-19. All patients were prospectively examined at the following time points: 0, 7 days, 14 days, 21 days and 28 days after confirmation or exclusion of SARS-CoV-2.

Results: Infection was confirmed in a total of 5/20 health care workers and 10/19 patients. Among the patients positive for SARS-CoV-2 infection, the mortality rate was 36.8 %. The probability of death in patients infected with SARS-CoV-2 increased 8-fold (p = 0.03). Bacterial, fungal, and viral co-infection significantly decreased survival in these patients (p < 0.05). Additionally, the probability of death was much higher in patients older than 40 years of age (p = 0.032).

Conclusion: This study showed significantly higher mortality rate in COVID-19 patients with haematologic diseases compared to the non-infected patient group. Haematologic patients with COVID-19 have 50 % less chance of survival.

Keywords: COVID-19; Haematological malignancies; Hospital-acquired infection.

MeSH terms

  • Adult
  • Age Factors
  • Aged
  • Betacoronavirus
  • COVID-19
  • Coinfection / microbiology
  • Coinfection / mortality
  • Coinfection / virology
  • Coronavirus Infections / mortality*
  • Cross Infection / mortality*
  • Cross Infection / virology
  • Europe / epidemiology
  • Female
  • Health Personnel / statistics & numerical data
  • Hematologic Neoplasms / complications*
  • Humans
  • Male
  • Middle Aged
  • Pandemics
  • Pneumonia, Viral / mortality*
  • Prospective Studies
  • Risk Factors
  • SARS-CoV-2
  • Time Factors
  • Young Adult